BAP Education: Pre-Clinical Certificate
Background
Following a popular series of informal workshops, the BAP launched the Preclinical Certificate in Psychopharmacology in July 2001. All those involved in this field of research, as well as those working in other areas of the Life Sciences, are encouraged to attend.
The aim of this Certificate is to increase awareness of, interest and expertise in, preclinical psychopharmacology through the provision of a series of training modules which will cover key aspects of research on animals and humans as well as career development in this field.
- This course will benefit novice and experienced psychopharmacologists, as well as those working in related fields, by encouraging appraisal and refinement of experimental design, in addition to providing training in essential skills.
- The programme comprises eight separate modules which will be run over a two-year cycle.
- Particular attention will be given to design of experiments using animals with an emphasis on refinement, reduction and prospects for replacement.
- Guidance and suggestions of career options for young psychopharmacologists will be given.
- All the modules will consist of talks, given by members of the BAP and other learned societies, and interactive sessions in which participants are encouraged to raise questions and share their ideas on best practice.
- To ensure maximal interaction between the speakers and participants, attendance at each of the full day modules will be limited to a maximum of 40.
Guidelines for completion of the BAP Certificate in Preclinical Psychopharmacology (BAPCPP)
Planning Committee
- Katie Hewitt (BAP Education Development and Delivery Coordinator)
- Clare Stanford (Course Director)
- Charles Marsden
- Secretary for Preclinical External Affairs
- Industrial Co-opted Member of Council
- Preclinical Member of Council
Further Information
Costs
From July 2009
Delegates at half-day modules will pay a nominal fee for attendance.
Delegates at full-day modules will pay the following fees:
- Students (includes PhD, MPhil): £55
- Academics (includes postdoc): £95
- Industry: £175
A nominal fee of £25.00 will be charged to delegates wanting to complete Part II of the certificate.
NB: Fees may have to change depending on the location and on-site costs of full-day modules.
The BAP acknowledges financial support from the BBSRC to develop this certificate programme
Forthcoming Modules
Click the event title for further details:
- Module 6: Principles Of Psychiatry For Basic Scientists
(Optional Module) Not yet booking
4th November 2010 at Bristol, TBC
Online Booking not available for this module - Module 7: Experimental Design 2; Preclinical models in behavioural pharmacology
(Core Module) Not yet booking
January 2011 TBC, at University of Sussex, Brighton,
Online Booking not available for this module - Module 8, Combining neurobiology and behaviour
(Core Module) Not yet booking
May 2011 TBC, at University of Nottingham, NG7 2RD
Online Booking not available for this module - Module 1: Genomics, Proteomics And Psychopharmacology
(Optional Module)
24th July 2011 at Harrogate,
Online Booking not available for this module - Module 2: Scientific Validity In Experimental Psychopharmacology
(Core Module)
October 2011 TBC, at TBC,
Online Booking not available for this module - Module 3: Experimental Design 1; Statistics And Experimental Design
(Core Module)
February 2012 TBC, at TBA,
Online Booking not available for this module - Module 4: Pharmacokinetics In Preclinical Psychopharmacology
(Core Module)
May 2012 TBC, at TBC,
Online Booking not available for this module - Module 5: Functional And Advanced Techniques – The development of pharmacological agents
(Optional Module)
July 2012 TBC, at TBC,
Online Booking not available for this module
Latest News
Subscribe to the News Feed 
- InVivoStat Statistical Analysis on
23rd August 2010
New BAP Education web page describing InVivoStat: The Statistical Tool for all Psychopharmacologists. Click here to read more InVivoStat - Information for the Public on
4th August 2010
We are pleased to launch our Public Web Pages. These are intended for members of the public with an interest in psychopharmacology. Public Web Page - Review of Mental Health Research on
5th July 2010
In 2009, BAP contributed to the Medical Research Council’s Review of Mental Health Research. The Report has recently been published. A summary report may be found here; MRC Mental Health Research Summary Report. Professor Barbara Sahakian, who will become BAP President-elect later this month, has written an article in the Lancet “A UK strategy for mental health and wellbeing”, also available here; Lancet article